Alert Done Done Edit In progress Play Run workshop Download Down Close All modules Educator In progress Learner How to Delete Information Credits Undo Time Left Right Right Down Locked Hide Home Menu Twitter LinkedIn icons.facebook Plus

5-minute learning

These short videos summarize complex clinical topics in 5-minute animations, helping you to keep up-to-date with best practice across the spectrum of care in oncology.

Available Modules

New

CME Credits: 0.25

ESMO 2023 highlights: Key updates in biomarker-driven NSCLC and thyroid cancer therapy

Professor Fernando López-Ríos

Professor Fernando López-Ríos covers some key highlights relating to biomarker-driven therapy in NSCLC and thyroid cancer from the ESMO 2023 Congress.

CME Credits: 0.25

The impact of long-term follow-up data in CDK4/6 inhibitors for early breast cancer

Prof. Dr. Nadia Harbeck

Professor Nadia Harbeck provides an overview of what long-term data can tell us about the role of CDK4/6 inhibitors when managing patients with early breast cancer.

Accreditation Expired

SABCS 2022 highlights: CDK 4/6 inhibitors and risk assessment and stratification for HR+/HER2- breast cancer

Professor Hope Rugo

Professor Hope Rugo and Professor Giuseppe Curigliano discuss practice-influencing developments in the treatment of HR+/HER2- breast cancer presented at SABCS 2022.

Accreditation Expired

Highlights in precision medicine for thyroid cancer presented at ESMO 2022

Dr. Jaume Capdevila

In this short video Dr. Jaume Capdevila covers some key highlights relating to precision medicine in the management of thyroid cancer from the recent ESMO 2022 Congress.

Accreditation Expired

Highlights in precision medicine for NSCLC presented at ESMO 2022

Professor Julien Mazières

In this short video Professor Julien Mazières covers some key highlights relating to precision medicine in the management of NSCLC from the recent ESMO 2022 Congress.

Accreditation Expired

Highlights in precision medicine for primary CNS cancer presented at ESMO 2022

Dr. John de Groot

In this short video Dr. John de Groot covers some key highlights relating to precision medicine in the management of primary CNS cancer from the recent ESMO 2022 Congress.

Accreditation Expired

Biomarker-driven approaches: Combined prevalence and individual outcomes

Dr. Robin Cornelissen

In this recorded plenary from the World Conference on Lung Cancer (WCLC), Dr. Robin Cornelissen gives an expert insight into the biomarker-driven treatment landscape for NSCLC.

Accreditation Expired

Implementation and interpretation of biomarker testing in NSCLC

Professor Fernando López-Ríos

In this recorded plenary from the World Conference on Lung Cancer (WCLC), Professor Fernando López-Ríos discusses the implementation of biomarker testing in NSCLC.

Accreditation Expired

Immune Checkpoint Inhibitors at the ESMO Immuno-Oncology Congress

Dr. Raffaele Califano

In these short videos our experts cover some highlights relating to immune checkpoint inhibitors from the recent ESMO Immuno-Oncology Congress.

Accreditation Expired

CDK 4/6 inhibitors in EBC

Prof. Dr. Nadia Harbeck

Professor Nadia Harbeck discusses the role of CDK4/6 inhibitors when managing patients with early breast cancer.

Accreditation Expired

Thyroid cancer pathology and efficient biomarker testing in the precision-medicine era

Professor Fernando López-Ríos

In these videos we speak with Professor Fernando López-Ríos about best practice when identifying thyroid cancer patients who are eligible for precision therapies.

Accreditation Expired

Identifying and treating RET and NTRK-altered thyroid cancer patients

Dr. Lori Wirth

In these videos we speak with Dr Lori Wirth about best practice when identifying and treating RET and NTRK-altered thyroid cancer patients.

Unaccredited

NTRK Fusions at the WCLC

Dr Drilon Dr Alexander Drilon

Watch this animation for a quick round-up of the NTRK data presented at the world conference on lung cancer 2020.

Accreditation Expired

RET Inhibition: European Guidance Explained

Professor Penault-Llorca gives an overview of the latest European guidance on detecting and targeting RET-altered cancers.